Amundi Index Solutions - Amundi Index MSCI Europe RE-CRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 17.5 | -4.2 | 13.2 | 5.2 | |
+/-Cat | -2.1 | 2.2 | 4.1 | 1.7 | 0.9 | |
+/-B’mrk | -0.4 | -0.1 | 0.4 | 0.0 | 0.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 16/05/2024 | EUR 205.80 | |
Day Change | -0.15% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0987205969 | |
Fund Size (Mil) 16/05/2024 | EUR 4122.24 | |
Share Class Size (Mil) 15/05/2024 | EUR 298.88 | |
Max Initial Charge | 4.50% | |
Ongoing Charge 11/02/2022 | 0.25% |
Investment Objective: Amundi Index Solutions - Amundi Index MSCI Europe RE-C |
To track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Isabelle Lafargue 07/09/2015 | ||
Inception Date 08/04/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index MSCI Europe RE-C | 14/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.84 |
ASML Holding NV | Technology | 3.27 |
Nestle SA | Consumer Defensive | 2.49 |
AstraZeneca PLC | Healthcare | 2.13 |
Shell PLC | Energy | 2.12 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index MSCI Europe RE-C |